Literature DB >> 27996163

Study of IL4-590C/T and IL6-174G/C Gene Polymorphisms in Type 2 Diabetic Patients With Chronic Kidney Disease in North Indian Population.

Km Neelofar1, Jamal Ahmad1, Arif Ahmad2, Khursheed Alam1.   

Abstract

To explore the associations between potential functional promoter polymorphisms in pro-inflammatory and anti-inflammatory (IL-4(-590C/T) and IL-6(-174G/C) cytokine genes, and kidney dysfunction in North Indian type 2 diabetic subjects with chronic kidney disease. A total of 150 subjects aged 25-75 year were included in this study. The glomerular filtration rate (GFR) and serum creatinine were estimated. PCR was performed to analyse genotype distribution in IL-4 (-590T/C) and IL-6 (-174G/C) among healthy, type 2 diabetic patients with or without CKD. The genotype distributions were determined by Hardy-Weinberg equilibrium. CKD patients showed lower GFR (59.36 ± 1.33 ml/min/1.73 m2 ) and higher serum creatinine (1.93 ± 0.99% mg) level in comparison to diabetic patients without CKD and healthy subjects. Genotypic distribution of the different genotypes among the study groups in IL-4 gene was genotype CC = 30, TC = 12, and TT = 8 in CKD patients. In type 2 diabetic patients without CKD, genotype distribution was CC = 38, TC = 10, and TT = 2. In healthy subjects, distribution of genotype was CC = 35, TC = 14, and TT = 1. The distribution of different genotype among the study groups for IL-6 gene was GG = 27, GC = 20, and CC = 3 in healthy subjects; GG = 28, GC = 19, and CC = 3 in diabetic patients without CKD and GG = 38, GC = 11, and CC = 1 in diabetic patients with CKD. There was no significant difference in the distribution of genotype frequencies between healthy subjects and diabetic patients without CKD but a significant difference was found in diabetic patients with CKD. The functional promoter polymorphisms IL4-590C/T and IL6-174G/C, which affect the IL-4 and IL-6 levels in north Indian subjects, were associated with kidney dysfunction and CKD. J. Cell. Biochem. 118: 1803-1809, 2017.
© 2016 Wiley Periodicals, Inc. © 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  CKD; GENE POLYMORPHISM; IL-4; IL-6; TYPE 2 DIABETES

Mesh:

Substances:

Year:  2017        PMID: 27996163     DOI: 10.1002/jcb.25853

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  6 in total

1.  Interleukin-4 (IL4) -590C/T (rs2243250) gene polymorphism is not associated with diabetic nephropathy (DN) in Caucasians with type 2 diabetes mellitus (T2DM).

Authors:  Matej Završnik; Jernej Letonja; Jana Makuc; Maja Šeruga; Ines Cilenšek; Daniel Petrovič
Journal:  Bosn J Basic Med Sci       Date:  2018-11-07       Impact factor: 3.363

2.  IL-6 gene rs1800795 polymorphism and diabetes mellitus: a comprehensive analysis involving 42,150 participants from a meta-analysis.

Authors:  Zhiying Cheng; Chunmin Zhang; Yuanyuan Mi
Journal:  Diabetol Metab Syndr       Date:  2022-07-15       Impact factor: 5.395

3.  Interleukin 6 (rs1800795) and pentraxin 3 (rs2305619) polymorphisms-association with inflammation and all-cause mortality in end-stage-renal disease patients on dialysis.

Authors:  Susana Rocha; Maria João Valente; Susana Coimbra; Cristina Catarino; Petronila Rocha-Pereira; José Gerardo Oliveira; José Madureira; João Carlos Fernandes; Maria do Sameiro-Faria; Vasco Miranda; Luís Belo; Alice Santos-Silva; Elsa Bronze-da-Rocha
Journal:  Sci Rep       Date:  2021-07-20       Impact factor: 4.379

4.  RNA sequencing of isolated cell populations expressing human APOL1 G2 risk variant reveals molecular correlates of sickle cell nephropathy in zebrafish podocytes.

Authors:  Joseph L Bundy; Blair R Anderson; Ludmila Francescatto; Melanie E Garrett; Karen L Soldano; Marilyn J Telen; Erica E Davis; Allison E Ashley-Koch
Journal:  PLoS One       Date:  2019-06-03       Impact factor: 3.240

5.  Canagliflozin reduces inflammation and fibrosis biomarkers: a potential mechanism of action for beneficial effects of SGLT2 inhibitors in diabetic kidney disease.

Authors:  Hiddo J L Heerspink; Paul Perco; Skander Mulder; Johannes Leierer; Michael K Hansen; Andreas Heinzel; Gert Mayer
Journal:  Diabetologia       Date:  2019-04-17       Impact factor: 10.122

6.  Association of IL-10 (- 1082 A/G) and IL-6 (- 174 G/C) gene polymorphism with type 2 diabetes mellitus in Ethiopia population.

Authors:  Birhanu Ayelign; Markos Negash; Henok Andualem; Tadelo Wondemagegn; Eyuel Kassa; Tewodros Shibabaw; Yonas Akalu; Meseret Derbew Molla
Journal:  BMC Endocr Disord       Date:  2021-04-15       Impact factor: 2.763

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.